Homeyahoo-finance2
Alnylam Pharmaceuticals Inc
Indicative price
$159.89
Nov 3, 2026
1
Funds holding
$74.8M
Reported value
248,396
Reported shares
Company profile
Stage
Country
Mark dateNov 3, 2026
Price history
Price per share in USD
Nov 3, 2026O $158.94H $161.58L $156.72C $159.89
Current funds holding Alnylam Pharmaceuticals Inc
| Fund | Manager | As of | Shares | Fair value | % of fund | AUM |
|---|---|---|---|---|---|---|
| T. Rowe Price Capital Appreciation Equity ETF TCAF | T. Rowe Price | Jun 30, 2026 | 248,396 | $74,774,648 | 1.0% | $7.4B |
Published ownership history
Historical positions are grouped by fund and accepted SEC portfolio snapshot.
| Fund | As of | Filing | Shares | Fair value | % of fund |
|---|---|---|---|---|---|
| T. Rowe Price Capital Appreciation Equity ETF | Jun 30, 2026 | NPORT-P | 248,396 | $74,774,648 | 1.0% |
| T. Rowe Price Capital Appreciation Equity ETF | Mar 31, 2026 | NPORT-P | 149,404 | $49,433,301 | 0.8% |
| T. Rowe Price Capital Appreciation Equity ETF | Jun 30, 2025 | NPORT-P | 36,559 | $11,921,524 | 0.2% |
| T. Rowe Price Capital Appreciation Equity ETF | Mar 31, 2025 | NPORT-P | 26,393 | $7,126,638 | 0.2% |
| T. Rowe Price Capital Appreciation Equity ETF | Dec 31, 2024 | NPORT-P | 12,916 | $3,039,264 | 0.1% |
| BlackRock Capital Allocation Term Trust | Dec 31, 2021 | NPORT-P | 7,195 | $1,220,128 | 0.1% |
| BlackRock Capital Allocation Term Trust | Sep 30, 2021 | NPORT-P | 11,421 | $2,156,399 | 0.1% |
| BlackRock Capital Allocation Term Trust | Jun 30, 2021 | NPORT-P | 7,766 | $1,316,492 | 0.1% |